
    
      This single-center, randomized, open-lable, single-dose, two-cycle,cross-over design
      bioequivalence test was conducted in subjects under fasting conditions. Subjects were fasted
      for at least 10 hours overnight in each cycleï¼Œbut can't ban their from drinking water.The
      next morning according to test-reference (TR) or Reference-test (RT) sequential oral
      perindopril tert-butylamine tablets (4 mg, 240 mL warm water) . Each period was separated
      with a 14-day washout period in fasted trials. The blood concentrations of perindopril and
      perindoprilat in qualified subjects were tested. Safety assessment includes vital signs
      examination, physical examination, laboratory safety examination, coagulation examination,
      electrocardiogram and adverse event reports.
    
  